Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.19 USD | -0.45% |
|
+12.89% | +93.81% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Felix Kim
FOU | Founder | - | 15-03-31 |
Martin Lehr
FOU | Founder | 40 | 15-03-31 |
Director of Finance/CFO | 46 | 21-10-31 | |
Priya Marreddy
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-31 |
Christopher Beck
COO | Chief Operating Officer | - | 22-01-04 |
Alex Levit
LAW | General Counsel | 45 | 21-03-31 |
Evan G. Dick
PRN | Corporate Officer/Principal | 72 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Berman
CHM | Chairman | 81 | 21-02-28 |
Jennifer Stacey
BRD | Director/Board Member | 59 | 21-02-28 |
Philip Kantoff
BRD | Director/Board Member | 69 | 18-11-30 |
Linda West
BRD | Director/Board Member | 64 | 21-02-28 |
Martin Lehr
FOU | Founder | 40 | 15-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 74,998,312 | 72,912,907 ( 97.22 %) | 0 | 97.22 % |
Company contact information
Context Therapeutics, Inc.
2001 Market Street Unit 15
19103, Philadelphia
+
http://www.contexttherapeutics.com![address Context Therapeutics Inc.](https://cdn.zonebourse.com/static/address/125228671.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- Stock
- Stock
- Company Context Therapeutics Inc.